APA

Yang T., Lu S., Chao Y., Sheen I., Lin C., Wang T., Chen S., Wang J., Liao L., Thomson J. A., Wang-Peng J., Chen P. & Chen L. (20101025). A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. : British journal of cancer.

Chicago

Yang T-S, Lu S-N, Chao Y, Sheen I-S, Lin C-C, Wang T-E, Chen S-C, Wang J-H, Liao L-Y, Thomson J A, Wang-Peng J, Chen P-J and Chen L-T. 20101025. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. : British journal of cancer.

Harvard

Yang T., Lu S., Chao Y., Sheen I., Lin C., Wang T., Chen S., Wang J., Liao L., Thomson J. A., Wang-Peng J., Chen P. and Chen L. (20101025). A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. : British journal of cancer.

MLA

Yang T-S, Lu S-N, Chao Y, Sheen I-S, Lin C-C, Wang T-E, Chen S-C, Wang J-H, Liao L-Y, Thomson J A, Wang-Peng J, Chen P-J and Chen L-T. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. : British journal of cancer. 20101025.